首页> 外文OA文献 >Aprotinin is a potent multi-target drug for the combination therapy of moderate COVID-19 cases

【2h】

Aprotinin is a potent multi-target drug for the combination therapy of moderate COVID-19 cases

机译：Aprotinin是一种有效的多目标药物，适用于中度Covid-19案例的组合治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andrey Ivashchenko; Valeria Azarova; Alina Egorova; Ruben Karapetian; Dmitry Kravchenko; Natalia Krivonos; Vladimir Loginov; Stanislav Poyarkov; Elena Merkulova; Olga Rosinkova; Nikolay Savchuk; Mikhail Topr; Elena Simakina; Elena Yakubova; Alexandre Ivachtchenko;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model [J] . Yi Gou, Zhenlei Zhang, Dongyang Li, Drug delivery. . 2018,第1期

机译：基于HSA的多目标联合疗法：在乳腺癌模型中调节药物从HSA的释放并克服单一耐药性
2. Chemoinformatics in multi-target drug discovery for anti-cancer therapy: In silico design of potent and versatile anti-brain tumor agents [J] . Speck-PlancheA., KleandrovaV.V., LuanF., Anti-cancer agents in medicinal chemistry . 2012,第6期

机译：化学信息学在用于抗癌治疗的多目标药物发现中：有效且通用的抗脑肿瘤药物的计算机设计
3. Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents. [J] . Speck Planche A, Kleandrova VV, Luan F, Bioorganic and medicinal chemistry . 2011,第21期

机译：抗癌治疗中的多靶点药物发现：基于片段的方法设计有效且用途广泛的抗前列腺癌药物。
4. Potent Antibody-Drug Conjugates for Cancer Therapy [C] . Paul J. Carter Controlled Release Society Annual Meeting and Exposition . 2007

机译：强大的抗体-药物结合物可用于癌症治疗
5. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. [D] . Khdair, Ayman Abed. 2008

机译：纳米粒子介导的化学疗法和光动力疗法相结合，克服了肿瘤的耐药性。
6. HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model [O] . Yi Gou, Zhenlei Zhang, Dongyang Li, 2018

机译：基于HSA的多目标联合疗法：在乳腺癌模型中调节药物从HSA的释放并克服单一耐药性
7. Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients [O] . Andrey A. Ivashchenko, Valeria N. Azarova, Alina N. Egorova, 2021

机译：抑肽酶和Avifavir®联合疗法对中等Covid-19患者的影响

Aprotinin is a potent multi-target drug for the combination therapy of moderate COVID-19 cases

著录项

引文网络

相似文献

相关主题

期刊订阅